LeadIQ logo
Learn more at LeadIQ.com

Insights

Financial Challenges Eiger BioPharmaceuticals is currently navigating Chapter 11 bankruptcy proceedings, which may impact their operational priorities and open opportunities for financial or operational support solutions.

Asset Divestitures The recent sale of key assets, including avexitide to Amylyx Pharmaceutical, indicates a potential need for alternative development partnerships, licensing agreements, or clinical trial support to sustain their portfolio.

Innovative Therapy Focus Eiger specializes in rare metabolic disease therapies, offering opportunities to collaborate on specialized drug development, regulatory strategy, or market access solutions tailored to niche markets.

Leadership Transition With recent leadership changes including the appointment of an interim CEO, there may be a window for strategic engagement around organizational support, staffing solutions, or executive consulting.

Market Potential and Size Targeting rare diseases with breakthrough designations and ongoing clinical programs presents an opportunity to provide diagnostics, companion tools, or patient engagement platforms aligned with their innovative pipeline.

Eiger BioPharmaceuticals Tech Stack

Eiger BioPharmaceuticals uses 8 technology products and services including cdnjs, Drupal, MySQL, and more. Explore Eiger BioPharmaceuticals's tech stack below.

  • cdnjs
    Content Delivery Network
  • Drupal
    Content Management System
  • MySQL
    Database
  • Module Federation
    Development
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security
  • X-Content-Type-Options
    Web & Portal Technology
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Eiger BioPharmaceuticals's Email Address Formats

Eiger BioPharmaceuticals uses at least 1 format(s):
Eiger BioPharmaceuticals Email FormatsExamplePercentage
FLast@eigerbio.comJDoe@eigerbio.com
49%
LFirst@eigerbio.comDJohn@eigerbio.com
1%
Last@eigerbio.comDoe@eigerbio.com
1%
FLast@eigerbio.comJDoe@eigerbio.com
49%

Frequently Asked Questions

Where is Eiger BioPharmaceuticals's headquarters located?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's main headquarters is located at 2155 Park Boulevard Palo Alto, California 94306 United States. The company has employees across 2 continents, including North AmericaSouth America.

What is Eiger BioPharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Eiger BioPharmaceuticals's main corporate office by phone at
+1-650-272-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eiger BioPharmaceuticals's stock symbol?

Minus sign iconPlus sign iconEiger BioPharmaceuticals is a publicly traded company; the company's stock symbol is EIGRQ.

What is Eiger BioPharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's official website is eigerbio.com and has social profiles on LinkedIn.

What is Eiger BioPharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eiger BioPharmaceuticals have currently?

Minus sign iconPlus sign iconAs of December 2025, Eiger BioPharmaceuticals has approximately 26 employees across 2 continents, including North AmericaSouth America. Key team members include Chief Business Officer: J. S.Chief Financial Officer: J. W.Chief Financial Officer: S. R.. Explore Eiger BioPharmaceuticals's employee directory with LeadIQ.

What industry does Eiger BioPharmaceuticals belong to?

Minus sign iconPlus sign iconEiger BioPharmaceuticals operates in the Biotechnology Research industry.

What technology does Eiger BioPharmaceuticals use?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's tech stack includes cdnjsDrupalMySQLModule FederationYoast SEOreCAPTCHAX-Content-Type-OptionsAcquia Cloud Site Factory.

What is Eiger BioPharmaceuticals's email format?

Minus sign iconPlus sign iconEiger BioPharmaceuticals's email format typically follows the pattern of FLast@eigerbio.com. Find more Eiger BioPharmaceuticals email formats with LeadIQ.

How much funding has Eiger BioPharmaceuticals raised to date?

Minus sign iconPlus sign icon As of December 2025, Eiger BioPharmaceuticals has raised $5M in funding. The last funding round occurred on Jun 07, 2022 for $5M.

Eiger BioPharmaceuticals

Biotechnology ResearchCalifornia, United States11-50 Employees

Eiger is a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic diseases. Eiger's lead product candidate, avexitide, is a well characterized, first-in-class GLP-1 antagonist for the treatment of post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI). Avexitide is the only drug in development for PBH with Breakthrough Therapy designation from the FDA.
 
For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.

For our social media and community guidelines, including information on how to report adverse events, please visit www.eigerbio.com/social-media-guidelines/

Section iconCompany Overview

Headquarters
2155 Park Boulevard Palo Alto, California 94306 United States
Phone number
+1-650-272-****
Website
eigerbio.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EIGRQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $1M$10M

    Eiger BioPharmaceuticals's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5M

    Eiger BioPharmaceuticals has raised a total of $5M of funding over 10 rounds. Their latest funding round was raised on Jun 07, 2022 in the amount of $5M.

  • $1M$10M

    Eiger BioPharmaceuticals's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. S.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. W.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. R.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. F.
    Vp, Clinical Strategy
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. C.
    Senior Vice President
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    H. R.
    Senior Director, Analytical Development And Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. A.
    Senior Director Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Director Of Accounting
    Phone icon
    Mobile Phone
  • Stylized image of a person
    X. X.
    Regulatory Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. D.
    Consultant Pharmacist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.